Table 2 Incidence rate ratios (RR)⁺ and 95% confidence interval comparing utilization outcomes after the onset of the pandemic on March 2020 through March 2021 to pre-pandemic period between March 2018 and February 2020

HbA1C measurements

Reference

0.43 [0.28, 0.65]

Reference

0.47 [0.36, 0.60]

0.86 [0.66, 1.12]

0.92 [0.65, 1.30]

All outpatient care visits

0.75 [0.66, 0.86]

0.77 [0.69, 0.85]

0.92 [0.81, 1.04]

1.04 [0.87, 1.24]

In-person outpatient care visits

0.44 [0.34, 0.56]

0.44 [0.37, 0.53]

0.65 [0.53, 0.79]

0.81 [0.62 1.05]

Telehealth outpatient care visits

2.35 [2.11, 2.62]

2.44 [2.17, 2.75]

2.26 [1.96, 2.60]

2.27 [1.94, 2.66]

In-person primary care visits

0.59 [0.44, 0.80]

0.59 [0.49, 0.71]

0.75 [0.62, 0.91]

1.32 [1.03, 1.68]

Telehealth primary care visits

2.35 [2.10, 2.62]

2.34 [2.08, 2.63]

2.32 [2.03, 2.65]

2.19 [1.83, 2.63]

Diabetes prescription fills

1.05 [0.99, 1.12]

1.02 [0.96, 1.09]

1.09 [1.02, 1.17]

1.07 [0.98, 1.17]

Hypertension prescription fills

1.01 [0.95, 1.07]

0.99 [0.94, 1.04]

0.99 [0.94, 1.04]

1.05 [0.99, 1.13]